HIV News and Research

RSS

Immigration influences HIV diagnosis demographics

HIV-positive individuals born outside the USA are a heterogenous population but have significant demographic differences to infected patients born within in the USA, research reveals.

8 Aug 2012

UAB program helps reduce incidence of HIV/AIDS in the U.S.

In the year since the University of Alabama at Birmingham emergency department began offering HIV screening for all patients ages 19-64, doctors say 20,000 tests were performed and 72 cases of HIV infection were diagnosed.

8 Aug 2012

Malawi launches week-long campaign to test 250,000 people for HIV

"Malawi on Monday launched a week-long campaign to test 250,000 people for HIV in what health authorities called a crucial intervention in a country ravaged by AIDS," Agence France-Presse reports.

8 Aug 2012

Clinton discusses global HIV efforts with South African officials during 11-day African tour

U.S. Secretary of State Hillary Clinton on Tuesday visited officials in South Africa and discussed the response to HIV/AIDS, the Associated Press/Huffington Post reports. Speaking with Foreign Minister Maite Nkoana-Mashabane "in the second cabinet-level strategic dialogue between the two nations," Clinton said "that global efforts to stop the virus 'have saved hundreds of thousands of lives,'" the news service writes.

8 Aug 2012

Article describes feasibility and costs of active tuberculosis case finding project in Cape Town

A research article by Katharina Kranzer from the London School of Hygiene & Tropical Medicine and colleagues describe the feasibility and costs of an active tuberculosis case finding project in Cape Town, South Africa.

8 Aug 2012

GeneXpert TB test maker Cepheid signs deals with PEPFAR, USAID, others to provide lower-cost kits

Diagnostics company Cepheid on Monday signed deals with PEPFAR, USAID, UNITAID, and the Bill & Melinda Gates Foundation to immediately reduce the price of its Xpert MTB/RIF test kit for its GeneXpert tuberculosis (TB) diagnostic system in 145 countries, Reuters reports.

8 Aug 2012

BioDiem granted European patent for antimicrobial drug

Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.

7 Aug 2012

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

BioDiem recently signed a collaborative agreement with The Royal Melbourne Institute of Technology (RMIT) for the development of non-influenza vaccines using BioDiem’s proprietary live attenuated influenza virus (LAIV) technology.

7 Aug 2012

Cannabis-based medications prove effective in relieving pain

Cannabis-based medications have been proved to relieve pain. This is the conclusion drawn by Franjo Grotenhermen and Kirsten Müller-Vahl in issue 29-30 of Deutsches Ärzteblatt International.

7 Aug 2012

Advances in HIV/AIDS therapy and the International AIDS Conference: an interview with Professor Sharon Lewin

The anti-HIV drugs, also known as anti-retroviral therapy, came about in the mid ‘90’s. These involved using at least 3 different drugs together.

7 Aug 2012

IPS reports on efforts to prevent mother-to-child HIV transmission at public hospital in Cameroon

"For nearly two years, not a single child with HIV has been born at the public hospital in the Cite-Verte district of Yaounde, the capital of Cameroon," Inter Press Service reports, adding, "Emilien Fouda, the hospital's director, says this proud record is the result of combined effort by his staff and community support groups."

7 Aug 2012

Vorinostat drives HIV from hiding

The addition of vorinostat to current antiretroviral therapy regimens can potentially help to eradicate hidden pockets of dormant human immunodeficiency virus, according to study results published in Nature.

6 Aug 2012

Clinton expresses concern over HIV in Uganda, stops in Malawi on 11-day African tour

U.S. Secretary of State Hillary Clinton "expressed concern" over Uganda's increasing number of HIV infections on a visit to the country last week, part of an 11-day trip to eight African nations, Uganda's New Vision reports (Mukasa, 8/4).

6 Aug 2012

U.N. urges Philippines to pass reproductive health bill amid protests from Catholic Church

"The United Nations has urged the Philippines to pass a bill that will allow the government to provide free contraceptives," BBC News reports (8/5).

6 Aug 2012

Blog examines impact of adolescent pregnancy in South Asia

As part of its monthly series Stories Behind the Statistics, "guest edited by FHI 360 on behalf of USAID'S IYWG, which provides technical leadership to improve the reproductive and sexual health of young people," the Bill & Melinda Gates Foundation's "Impatient Optimists" blog features a story by Gaj Bahadur Gurung, program coordinator for the National Federation of Women Living with HIV and AIDS in Nepal, who discusses the impact of adolescent pregnancy on girls and young women in South Asia.

6 Aug 2012

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.

6 Aug 2012

Science magazine recaps issues discussed at AIDS 2012

Science looks back at the XIX International AIDS Conference (AIDS 2012), which ended last week in Washington, D.C., writing, "The battle against HIV is having more success than ever. ... But several presentations made clear that a gulf separates aspirations from reality when it comes to 'ending AIDS,' which [Secretary of State Hillary] Clinton and many other prominent speakers at the conference emphasized was now possible."

3 Aug 2012

Panel discussion looks back on AIDS 2012, explores possible topics for AIDS 2014

Devex reports on a panel discussion held in Washington, D.C. Wednesday during which experts "looked back at the main surprises of the just-concluded [XIX International AIDS Conference (AIDS 2012)], and offered predictions on what the 2014 follow-up [in Melbourne, Australia] will focus on."

3 Aug 2012

Gilead Sciences signs deals with 3 Indian pharmaceutical companies to promote low-cost HIV drugs in developing countries

Gilead Sciences Inc. announced Thursday that it plans to partner with Mylan Inc., Ranbaxy Laboratories Ltd. and Strides Arcolab Ltd. "to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine in developing countries," the Wall Street Journal reports.

3 Aug 2012

Examining the role of collaborative partnerships in global response to HIV/AIDS

In this post in the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Rhonda Zygocki, executive vice president of policy and planning at Chevron, responds to questions about Chevron's presence at the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., last week, writing that such questions "give me an opportunity to talk about the critical role everyone plays in the global fight against this epidemic, including Chevron, as well as the ways collaborative partnerships will lead to the elimination of AIDS."

3 Aug 2012

HIV News and Research

Immigration influences HIV diagnosis demographics

UAB program helps reduce incidence of HIV/AIDS in the U.S.

Malawi launches week-long campaign to test 250,000 people for HIV

Clinton discusses global HIV efforts with South African officials during 11-day African tour

Article describes feasibility and costs of active tuberculosis case finding project in Cape Town

GeneXpert TB test maker Cepheid signs deals with PEPFAR, USAID, others to provide lower-cost kits

BioDiem granted European patent for antimicrobial drug

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

Cannabis-based medications prove effective in relieving pain

Advances in HIV/AIDS therapy and the International AIDS Conference: an interview with Professor Sharon Lewin

IPS reports on efforts to prevent mother-to-child HIV transmission at public hospital in Cameroon

Vorinostat drives HIV from hiding

Clinton expresses concern over HIV in Uganda, stops in Malawi on 11-day African tour

U.N. urges Philippines to pass reproductive health bill amid protests from Catholic Church

Blog examines impact of adolescent pregnancy in South Asia

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Science magazine recaps issues discussed at AIDS 2012

Panel discussion looks back on AIDS 2012, explores possible topics for AIDS 2014

Gilead Sciences signs deals with 3 Indian pharmaceutical companies to promote low-cost HIV drugs in developing countries

Examining the role of collaborative partnerships in global response to HIV/AIDS

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News